Published in Lancet on October 19, 1991
Clinical guidelines on the management of hepatitis C. Gut (2001) 1.72
HCV confirmatory testing of blood donors. Lancet (1992) 1.64
Storage conditions of blood samples and primer selection affect the yield of cDNA polymerase chain reaction products of hepatitis C virus. J Clin Microbiol (1992) 1.49
Significance of highly positive c22-3 "indeterminate" second-generation hepatitis C virus (HCV) recombinant immunoblot assay (RIBA) and resolution by third-generation HCV RIBA. J Clin Microbiol (1994) 1.26
Significance of indeterminate third-generation hepatitis C virus recombinant immunoblot assay. J Clin Microbiol (1996) 1.18
Prevalence and significance of hepatitis C virus (HCV) viremia in HCV antibody-positive subjects from various populations. J Clin Microbiol (1993) 0.99
Indeterminate results of the second-generation hepatitis C virus (HCV) recombinant immunoblot assay: significance of high-level c22-3 reactivity and influence of HCV genotypes. J Clin Microbiol (1997) 0.78
Evaluation of anti-HCV capsid indeterminate serum samples. Lancet (1992) 0.76
Clinician's guide to diagnostic tests for hepatitis C virus infections. Can J Infect Dis (1993) 0.75
The clinical virology of hepatitis C virus. Int J Exp Pathol (1994) 0.75
Infection with hepatitis C virus. New generation of assays should improve screening. BMJ (1994) 0.75
Haplotype tagging for the identification of common disease genes. Nat Genet (2001) 11.27
Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol (1993) 8.07
A survey of childhood asthma in Aberdeen. Lancet (1969) 7.86
The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem (1991) 7.22
Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection. J Virol (1993) 6.41
Estimates of bacterial growth from changes in uptake rates and biomass. Appl Environ Microbiol (1982) 6.11
Selective sorption of bacteria from seawater. Can J Microbiol (1971) 5.85
Contribution of particle-bound bacteria to total microheterotrophic activity in five ponds and two marshes. Appl Environ Microbiol (1982) 5.39
Detection of a novel DNA virus (TTV) in blood donors and blood products. Lancet (1998) 5.15
Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet (1996) 4.05
A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology (1994) 4.01
Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization. International Committee on Virus Taxonomy. Arch Virol (1998) 3.77
Managing patients with lung cancer. New guidelines should improve standards of care. BMJ (1999) 3.65
Convergent and divergent sequence evolution in the surface envelope glycoprotein of human immunodeficiency virus type 1 within a single infected patient. Proc Natl Acad Sci U S A (1992) 3.58
Statistical analysis of the direct count method for enumerating bacteria. Appl Environ Microbiol (1982) 3.37
Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. J Gen Virol (1992) 3.37
Testing of blood donations for hepatitis C virus. Lancet (1994) 3.27
The structure of the major cell processes of isolated BHK21 fibroblasts. Exp Cell Res (1969) 3.27
Infection with hepatitis G virus among recipients of plasma products. Lancet (1996) 3.25
Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5' non-coding region. J Gen Virol (1995) 3.10
Epidemiological profile and clinical associations of human bocavirus and other human parvoviruses. J Infect Dis (2006) 2.97
The occurrence of microvilli during spreading and growth of BHK21-C13 fibroblasts. Exp Cell Res (1970) 2.97
The DNA of a minute virus of mice. J Gen Virol (1969) 2.93
Variation of the hepatitis C virus 5' non-coding region: implications for secondary structure, virus detection and typing. The International HCV Collaborative Study Group. J Gen Virol (1995) 2.91
Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. J Clin Microbiol (1994) 2.90
Viral hepatitis markers in blood donors and patients with a history of jaundice. Lancet (1980) 2.90
Sequence variability in the 5' non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity. J Gen Virol (1993) 2.87
Rectal bleeding. Do other symptoms aid in diagnosis? Dis Colon Rectum (1989) 2.83
Concurrent evolution of human immunodeficiency virus type 1 in patients infected from the same source: rate of sequence change and low frequency of inactivating mutations. J Virol (1990) 2.68
Identification of shared populations of human immunodeficiency virus type 1 infecting microglia and tissue macrophages outside the central nervous system. J Virol (2001) 2.62
Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatology (1994) 2.60
Identification of genotypes of hepatitis C virus by sequence comparisons in the core, E1 and NS-5 regions. J Gen Virol (1994) 2.53
A cumulative review of studies on travellers, their experience of illness and the implications of these findings. J Infect (1990) 2.50
The ghost of Christmas past: health effects of poverty in London in 1896 and 1991. BMJ (2001) 2.49
Outbreak of acute hepatitis C following the use of anti-hepatitis C virus--screened intravenous immunoglobulin therapy. Gastroenterology (1996) 2.48
Health inequalities in Britain: continuing increases up to the end of the 20th century. J Epidemiol Community Health (2002) 2.46
Clinical significance of intrahepatic hepatitis C virus levels in patients with chronic HCV infection. Gut (1998) 2.45
Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3. J Clin Microbiol (1993) 2.36
Dapsone-trimethoprim for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Ann Intern Med (1986) 2.36
Identifying training and technical assistance needs in community coalitions: a developmental approach. Health Educ Res (1993) 2.34
Ecological aspects of microbial chemotactic behavior. Annu Rev Microbiol (1976) 2.31
The p53-dependent effects of macrophage migration inhibitory factor revealed by gene targeting. Proc Natl Acad Sci U S A (2003) 2.29
The origin of hepatitis C virus genotypes. J Gen Virol (1997) 2.26
Epithelial wound healing enhanced by transforming growth factor-alpha and vaccinia growth factor. Science (1987) 2.24
Detection of three types of hepatitis C virus in blood donors: investigation of type-specific differences in serologic reactivity and rate of alanine aminotransferase abnormalities. Transfusion (1993) 2.24
A highly divergent picornavirus in a marine mammal. J Virol (2007) 2.23
The influence of the New Pathway curriculum on Harvard medical students. Acad Med (1994) 2.23
Frequent infection of peripheral blood CD8-positive T-lymphocytes with HIV-1. Edinburgh Heterosexual Transmission Study Group. Lancet (1996) 2.20
Virus replication in enucleate cells: vesicular stomatitis virus and influenza virus. J Virol (1974) 2.19
Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer. J Clin Oncol (1999) 2.19
Defective particles in BHK cells infected with temperature-sensitive mutants of vesicular stomatitis virus. J Virol (1971) 2.14
Complete nucleotide sequence of a type 4 hepatitis C virus variant, the predominant genotype in the Middle East. J Gen Virol (1997) 2.13
Lysis of Escherichia coli by marine micro-organisms. Nature (1967) 2.09
Transposition of the Drosophila element mariner into the chicken germ line. Nat Biotechnol (1998) 2.09
Virus 'quasispecies': making a mountain out of a molehill? J Gen Virol (1997) 2.07
HTLV-III antibody in Edinburgh drug addicts. Lancet (1985) 2.03
Hepatitis C quantification and sequencing in blood products, haemophiliacs, and drug users. Lancet (1990) 2.01
Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: implications for virus classification. The International HCV Collaborative Study Group. J Gen Virol (1995) 2.00
Influence of HAART on HIV-related CNS disease and neuroinflammation. J Neuropathol Exp Neurol (2005) 1.98
No evidence for an association between infections with WU and KI polyomaviruses and respiratory disease. J Clin Virol (2007) 1.96
The DNAs of three parvoviruses. J Gen Virol (1970) 1.96
The molecular epidemiology of human immunodeficiency virus type 1 in Edinburgh. J Infect Dis (1995) 1.94
Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor. J Neurosci (1995) 1.94
Cimetidine in the treatment of duodenal ulcer: a multicenter double blind study. Gastroenterology (1978) 1.93
Detection, quantification and sequencing of HIV-1 from the plasma of seropositive individuals and from factor VIII concentrates. AIDS (1991) 1.93
The role of polymers in microbial aggregation. Annu Rev Microbiol (1973) 1.92
Vascular endothelial growth factor: a new member of the platelet-derived growth factor gene family. Biochem Biophys Res Commun (1989) 1.91
Characteristics of nucleotide substitution in the hepatitis C virus genome: constraints on sequence change in coding regions at both ends of the genome. J Mol Evol (1997) 1.88
Association of HLA types A1-B8-DR3 and B27 with rapid and slow progression of HIV disease. QJM (1996) 1.88
HTLV-III antibody in drug abusers in the west of Scotland: the Edinburgh connection. Lancet (1986) 1.88
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. Gut (2006) 1.87